Biological reactive intermediates that mediate dacarbazine cytotoxicityPOURAHMAD, Jalal; AMIRMOSTOFIAN, Marzieh; KOBARFARD, Farzad et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 89-96, issn 0344-5704, 8 p.Article

TREATMENT OF ADVANCED MALIGNANT HEMANGIOPERICYTOMA WITH COMBINATION ADRIAMYCIN AND DTIC: A REPORT OF FOUR CASES = TRAITEMENT DES HEMANGIOPERICYTOMES MALINS AVANCES PAR ASSOCIATION D'ADRIAMYCINE ET DE DTIC: A PROPOS DE QUATRE CASBEADLE GF; HILLCOAT BL.1983; JOURNAL OF SURGICAL ONCOLOGY; ISSN 0022-4790; USA; DA. 1983; VOL. 22; NO 3; PP. 167-170; ABS. ENG; BIBL. 19 REF.Article

PHOTOSENSITIVITY REACTION FOLLOWING DTIC ADMINISTRATION: REPORT OF TWO CASESBECK TM; HART NE; SMITH CE et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 725-726; BIBL. 5 REF.Article

EFFECTIVE TREATMENT OF KAPOSI'S SARCOMA WITH 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388)VOGEL CL; PRIMACK A; OWOR R et al.1973; CANCER CHEMOTHERAPY REP., I; U.S.A.; DA. 1973; VOL. 57; NO 1; PP. 65-71; BIBL. 12REF.Serial Issue

DTIC (NSC-45388) TOXICITYMOORE GE; MEISELBAUGH D.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 219Article

Fotosensibilidad por dacarbacina (DTIC) = Dacarbazine [DTIC]-induced photosensitivity reactionFERNANDEZ DE VILLATA, Maria José G; RUIZ-GENAO, Diana; SANCHEZ-PEREZ, Javier et al.Actas dermo-sifiliográficas (Ed. impresa). 2003, Vol 94, Num 8, pp 549-551, issn 0001-7310, 3 p.Article

5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) IN THE TREATMENT OF SOLID TUMORS IN CHILDRENFINKLESTEIN JZ; ALBO V; ERTEL I et al.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 351-357; BIBL. 8 REF.Article

Interaction of Dacarbazine and Imexon, In Vitro and In Vivo, in Human A375 Melanoma CellsSAMULITIS, Betty K; DORR, Robert T; CHOW, H.-H. Sherry et al.Anticancer research. 2011, Vol 31, Num 9, pp 2781-2785, issn 0250-7005, 5 p.Article

Mechanism of UVA-dependent DNA Damage Induced by An Antitumor Drug Dacarbazine in Relation to its PhotogenotoxicityIWAMOTO, Takuya; HIRAKU, Yusuke; OKUDA, Masahiro et al.Pharmaceutical research. 2008, Vol 25, Num 3, pp 598-604, issn 0724-8741, 7 p.Article

Re-evaluating the role of dacarbazine in metastatic melanoma : What have we learned in 30 years?EGGERMONT, Alexander M. M; KIRKWOOD, John M.European journal of cancer (1990). 2004, Vol 40, Num 12, pp 1825-1836, issn 0959-8049, 12 p.Article

Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosisSANADA, Masayuki; HIDAKA, Masumi; TAKAGI, Yasumitsu et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 12, pp 2657-2663, issn 0143-3334, 7 p.Article

REPRODUCTION AND TERATOLOGY STUDIES WITH ONCOLYTIC AGENTS IN THE RAT AND RABBIT. II. 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (DTIC).THOMPSON DJ; MOLELLO JA; STREBING RJ et al.1975; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1975; VOL. 33; NO 2; PP. 281-290; BIBL. 10 REF.Article

FATE OF THE RING MOIETY OF 5(3,3-DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE IN MAMMALIAN CELLSSAUNDERS PP; LIAN YU CHAO.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 10; PP. 2464-2469; BIBL. 11REF.Article

Dacarbazine : Déticène® = Dacarbazine : Deticene®QUEREUX, G; BROCARD, A; DRENO, B et al.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 12, pp 1001-1003, issn 0151-9638, 3 p.Article

Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivoLEV, Dina Chelouche; ONN, Amir; MELINKOVA, Vladislava O et al.Journal of clinical oncology. 2004, Vol 22, Num 11, pp 2092-2100, issn 0732-183X, 9 p.Article

CHEMOTHERAPY OF MALIGNANT MESOTHELIOMAGERNER RE; MOORE GE.1974; ONCOLOGY; SWITZ.; DA. 1974; VOL. 30; NO 2; PP. 152-155; BIBL. 5REF.Article

DROGAS ANTINEOPLASICAS = MEDICAMENT ANTICANCEREUXESTEVEZ ROBERTO A ED; ALVAREZ CARLOS A ED.1980; ; ARG; BUENOS AIRES: UNIVERSIDAD DEL SALVADOR; DA. 1980; 152 P.; 23 CM; BIBL. 15 REF.Book

TRAITEMENT DES MELANOMES MALINS. ESSAI D'UTILISATION DU D.T.I.C. EN PERFUSION INTRA-ARTERIELLEBANZET P; RICBOURG B; JACQUILLAT C et al.1975; NOUV. PRESSE MED.; FR.; DA. 1975; VOL. 4; NO 20; PP. 1477-1480 (3P.); ABS. ANGL.; BIBL. 6REF.Article

STUDY OF 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) IN PATIENTS WITH DISSEMINATED MELANOMA = ETUDE DU (DIMETHYL-3,3 TRIAZENO-1)-5 IMIDAZOLE CARBOXAMIDE-4 (NSC45388) CHEZ DES PATIENTS ATTEINTS DE MELANOMES DISSEMINESGERNER RE; MOORE GE.1973; CANCER CHEMOTHERAPY REP., I; U.S.A.; DA. 1973; VOL. 57; NO 1; PP. 83-84; BIBL. 5REF.Serial Issue

Phase I―II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaPLUMMER, R; LORIGAN, P; KAHATT, C et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1451-1459, issn 0007-0920, 9 p.Article

A Phase 1-2 Study of Imexon Plus Dacarbazine in Patients With Unresectable Metastatic MelanomaWEBER, Jeffrey S; SAMLOWSKI, Wolfram E; GONZALEZ, Rene et al.Cancer. 2010, Vol 116, Num 15, pp 3683-3691, issn 0008-543X, 9 p.Article

CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanomaKONJEVIC, G; JOVIC, V; VULETIC, A et al.European journal of clinical investigation. 2007, Vol 37, Num 11, pp 887-896, issn 0014-2972, 10 p.Article

DIMETHYLTRIAZENOIMIDAZOLE CARBOXAMIDE THERAPY OF MALIGNANT GLUCAGONOMASTRAUSS GM; WEITZMAN SA; AOKI TT et al.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 90; NO 1; PP. 57-58; BIBL. 5 REF.Article

NEUE SUBSTANZEN IN DER ONKOLOGISCHEN THERAPIE. = NOUVEAUX PRODUITS EN CANCEROLOGIECAVALLI F.1978; SCHWEIZ. MED. WSCHR.; CHE; DA. 1978; VOL. 108; NO 32; PP. 1222-1227; ABS. ENG; BIBL. 62 REF.Article

TREATMENT OF MOPP-RESISTANT HODGKIN'S DISEASE WITH ADRIAMYCIN, BLEOMYCIN, VINBLASTINE AND DACARBAZINE (ABVD)PAPA G; MANDELLI F; DE LUCA AM et al.1982; EUR. J. CANCER CLIN. ONCOL.; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 9; PP. 803-806; BIBL. 11 REF.Article